Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
22.72
+0.89 (4.08%)
At close: Feb 20, 2026, 4:00 PM EST
22.28
-0.44 (-1.94%)
After-hours: Feb 20, 2026, 7:20 PM EST
Ultragenyx Pharmaceutical Analyst Ratings
Total Analysts
19
Consensus Rating
Strong Buy
Price Target
$66.32
Upside
+191.90%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $128 → $79 | Strong Buy | Maintains | $128 → $79 | +247.71% | Feb 18, 2026 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $37 → $34 | Buy | Maintains | $37 → $34 | +49.65% | Feb 18, 2026 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $39 → $37 | Buy | Maintains | $39 → $37 | +62.85% | Feb 17, 2026 |
| Wedbush | Wedbush | Hold Reiterates $25 | Hold | Reiterates | $25 | +10.04% | Feb 17, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $60 → $50 | Strong Buy | Maintains | $60 → $50 | +120.07% | Feb 17, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +164.08% | Feb 3, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $80 → $60 | Strong Buy | Maintains | $80 → $60 | +164.08% | Jan 5, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $64 → $52 | Strong Buy | Maintains | $64 → $52 | +128.87% | Jan 5, 2026 |
| B of A Securities | B of A Securities | Strong Buy Maintains $72 → $58 | Strong Buy | Maintains | $72 → $58 | +155.28% | Jan 2, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $80 → $70 | Buy | Maintains | $80 → $70 | +208.10% | Dec 30, 2025 |
| Baird | Baird | Buy Maintains $72 → $47 | Buy | Maintains | $72 → $47 | +106.87% | Dec 30, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $65 → $45 | Buy | Maintains | $65 → $45 | +98.06% | Dec 30, 2025 |
| Jefferies | Jefferies | Strong Buy Maintains $114 → $63 | Strong Buy | Maintains | $114 → $63 | +177.29% | Dec 30, 2025 |
| Barclays | Barclays | Buy Maintains $81 → $50 | Buy | Maintains | $81 → $50 | +120.07% | Nov 24, 2025 |
| TD Cowen | TD Cowen | Strong Buy Maintains $86 → $75 | Strong Buy | Maintains | $86 → $75 | +230.11% | Nov 5, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $100 → $90 | Strong Buy | Maintains | $100 → $90 | +296.13% | Nov 5, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.